|
September 21, 2021
|
Progenity to Participate in 11th Annual Partnership Opportunities in Drug Delivery Conference
|
|
September 14, 2021
|
Progenity Announces Patent Granted by USPTO for its Preeclampsia Rule-Out Test
|
|
September 3, 2021
|
Progenity to Participate in Two Upcoming Investor Conferences
|
|
August 24, 2021
|
Progenity Announces Closing of $40 Million Underwritten Public Offering
|
|
August 19, 2021
|
Progenity Announces Pricing of $40 Million Public Offering of Common Stock and Warrants
|
|
August 19, 2021
|
Progenity Announces Proposed Underwritten Public Offering of Common Stock and Warrants
|
|
August 12, 2021
|
Progenity Provides Corporate Update and Reports Second Quarter 2021 Financial Results
|
|
August 5, 2021
|
Progenity to Report Second Quarter 2021 Financial Results and Provide Corporate Update
|
|
July 29, 2021
|
Progenity Announces Successful Completion of Clinical Validation Study and Achievement of the Primary Endpoint for its Preeclampsia Rule-Out Test
|
|
June 30, 2021
|
Progenity Announces Appointment of Surbhi Sarna to its Board of Directors
|
